XCUR
Exicure Inc
NASDAQ: XCUR · HEALTHCARE · BIOTECHNOLOGY
$3.36
+1.51% today
Updated 2026-04-30
Market cap
$22.12M
P/E ratio
—
P/S ratio
13.61x
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$3 – $12
Volume
0.0M
WallStSmart proprietary scores
24
out of 100
Grade: F
Strong Sell
Investment rating
6.3
Growth
B5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$2.00
-40.48%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 928.00% QoQ
Risks
- Thin margins at 0.00%
- Negative free cash flow $-1.36M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $28.83M | $0.00 | $500000.00 | $0.00 | $0.00 |
| Net income | $-2.58M | $-16.91M | $-9.70M | $-4.95M | $-2.90M |
| EPS | — | — | — | — | $-0.79 |
| Free cash flow | $-35.67M | $-10.36M | $-2.91M | $-8.56M | $-1.36M |
| Profit margin | -8.96% | — | -1,940.20% | — | — |
Peer comparison
Smart narrative
Exicure Inc trades at $3.36. Our Smart Value Score of 24/100 indicates the stock is weak.
Frequently asked questions
What is Exicure Inc's stock price?
Exicure Inc (XCUR) trades at $3.36.
Is Exicure Inc overvalued?
Smart Value Score 24/100 (Grade F, Strong Sell).
What is the price target of Exicure Inc (XCUR)?
The analyst target price is $2.00, representing -40.5% downside from the current price of $3.36.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio13.61x
ROE-92.50%
Beta4.02
50D MA$3.98
200D MA$4.98
Shares out0.01B
Float0.00B
Short ratio—
Avg volume0.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—